941854864	941854864	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
00232580	00232580	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7286905	7286905	CD	B-NP	O
|	|	CC	I-NP	O
7/24/2006	7/24/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
VOMITING	VOMITING	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/5/2006	6/5/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
12/10/2006	12/10/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
GIZINSKI	GIZINSKI	NNP	B-NP	O
,	,	,	O	O
LESLEY	LESLEY	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Marcel	Marcel	NNP	I-NP	O
Suders	Suders	NNP	I-NP	O
of	of	IN	B-PP	O
RH	RH	NN	B-NP	B-protein
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Vomiting	Vomiting	NN	B-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
AND	AND	CC	O	O
DIAGNOSIS	DIAGNOSIS	NNP	B-NP	O
:	:	:	O	O
Include	Include	NNP	B-NP	O
diabetes	diabete	VBZ	B-VP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
primary	primary	JJ	B-NP	O
biliary	biliary	JJ	I-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
51-year-old	51-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
who	who	WP	B-NP	O
vomited	vomit	VBD	B-VP	O
during	during	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
completed	complete	VBD	B-VP	O
her	her	PRP	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
,	,	,	O	O
went	go	VBD	B-VP	O
home	home	NN	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
multiple	multiple	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
non-biliary	non-biliary	JJ	B-NP	O
emesis	emesis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
po	po	NN	B-NP	O
's	's	POS	B-NP	O
including	include	VBG	B-PP	O
her	her	PRP$	B-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
report	report	VB	I-VP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
appetite	appetite	NN	B-NP	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
reluctant	reluctant	JJ	B-ADJP	O
to	to	TO	B-VP	O
eat	eat	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
concerns	concern	NNS	B-NP	O
about	about	IN	B-PP	O
vomiting	vomit	VBG	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
sick	sick	JJ	I-NP	O
contacts	contact	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
barbeque	barbeque	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
weekend	weekend	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
one	one	NN	I-NP	O
else	else	RB	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
picnic	picnic	NN	I-NP	O
was	be	VBD	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
sick	sick	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
feverish	feverish	JJ	B-NP	O
per	per	FW	I-NP	O
se	se	FW	I-NP	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
some	some	DT	B-NP	O
sensation	sensation	NN	I-NP	O
of	of	IN	B-PP	O
feeling	feeling	NN	B-NP	O
heated	heat	VBN	B-VP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
normal	normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
clear	clear	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
occurs	occur	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	I-NP	O
retching	retching	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
visual	visual	JJ	I-NP	O
changes	change	NNS	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
dysuria	dysuria	NN	B-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
increased	increase	VBN	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
urination	urination	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
admitted	admit	VBN	I-VP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
of	of	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
with	with	IN	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
resumption	resumption	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	B-protein
included	include	VBD	B-VP	I-protein
regular	regular	JJ	B-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
on	on	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
losartan	losartan	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
ursodiol	ursodiol	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Colace	Colace	NNP	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
taking	take	VBG	I-VP	O
clonidine	clonidine	NN	B-NP	O
0.1	0.1	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	NNP	B-NP	O
for	for	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
with	with	IN	B-PP	O
retinopathy	retinopathy	NN	B-NP	O
and	and	CC	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
stent	stent	JJ	I-NP	O
x4	x4	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
shown	show	VBN	B-VP	O
on	on	IN	B-PP	O
repeat	repeat	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
patent	patent	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
primary	primary	JJ	B-NP	O
biliary	biliary	JJ	I-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
polymyalgia	polymyalgia	NN	B-NP	O
rheumatica	rheumatica	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
and	and	CC	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cataract	cataract	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Though	Though	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
report	report	VB	I-VP	O
having	have	VBG	I-VP	O
any	any	DT	B-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
chart	chart	NN	I-NP	O
notes	note	VBZ	B-VP	O
unspecified	unspecified	JJ	B-NP	O
reactions	reaction	NNS	I-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
hypoglycemics	hypoglycemic	NNS	I-NP	O
and	and	CC	I-NP	O
calcitriol	calcitriol	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
use	use	VB	I-VP	O
tobacco	tobacco	NN	B-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
relatives	relative	NNS	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
97.8	97.8	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
79	79	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
148/79	148/79	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
were	be	VBD	B-VP	O
moist	moist	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
cervical	cervical	JJ	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
loud	loud	JJ	I-NP	O
3/6	3/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
best	best	RB	B-ADVP	O
heard	hear	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
nontender	nontender	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Bowel	Bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
rebound	rebound	NN	B-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Distal	Distal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Pertinent	Pertinent	JJ	B-NP	B-protein
labs	lab	NNS	I-NP	I-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
include	include	VBP	B-VP	O
:	:	:	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
with	with	IN	B-PP	O
81	81	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
and	and	CC	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
35.5	35.5	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
at	at	IN	B-PP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
amylase	amylase	NN	I-NP	B-protein
was	be	VBD	B-VP	O
82	82	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
lipase	lipase	NN	I-NP	I-protein
was	be	VBD	B-VP	O
15	15	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
stable	stable	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
interval	interval	JJ	I-NP	O
progression	progression	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mild	mild	JJ	I-NP	O
interstitial	interstitial	JJ	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
stable	stable	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
and	and	CC	I-NP	O
pelvis	pelvis	NN	I-NP	O
on	on	IN	B-PP	O
10/19/06	10/19/06	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
small	small	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
splenomegaly	splenomegaly	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
spleen	spleen	NN	I-NP	O
measuring	measure	VBG	B-VP	O
16	16	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
liver	liver	NN	I-NP	O
appeared	appear	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
other	other	JJ	I-ADJP	O
than	than	IN	B-PP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
focal	focal	JJ	B-NP	O
fat	fat	NN	I-NP	O
or	or	CC	I-NP	O
perfusion	perfusion	NN	I-NP	O
anomaly	anomaly	RB	B-ADJP	O
adjacent	adjacent	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
falciform	falciform	JJ	I-NP	O
ligament	ligament	NN	I-NP	O
.	.	.	O	O

Gallstones	Gallstone	NNS	B-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
stomach	stomach	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
were	be	VBD	B-VP	O
decompressed	decompress	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
findings	finding	NNS	I-NP	O
to	to	TO	B-VP	O
explain	explain	VB	I-VP	O
nausea	nausea	NN	B-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
bowel	bowel	NN	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MR	MR	NN	I-NP	B-protein
angio	angio	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
on	on	IN	B-PP	O
10/19/06	10/19/06	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Splenomegaly	Splenomegaly	RB	B-ADVP	O
,	,	,	O	O
cholelithiasis	cholelithiasis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
trace	trace	NN	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
51-year-old	51-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	O	O
hypertensive	hypertensive	JJ	B-NP	O
urgency	urgency	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
inability	inability	NN	I-NP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
her	her	PRP$	B-NP	O
p.o.	p.o.	FW	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
Reglan	Reglan	NN	B-NP	B-protein
initially	initially	RB	B-ADVP	I-protein
IV	IV	CD	B-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
p.o.	p.o.	FW	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
nausea	nausea	NN	I-NP	O
returned	return	VBD	B-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
Reglan	Reglan	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
,	,	,	O	O
so	so	IN	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
standing	standing	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
Reglan	Reglan	NN	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
find	find	VB	I-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
obstruction	obstruction	NN	B-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
findings	finding	NNS	I-NP	O
to	to	TO	B-VP	O
explain	explain	VB	I-VP	O
nausea	nausea	NN	B-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
MR	MR	NN	I-NP	B-protein
angiogram	angiogram	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
done	do	VBN	I-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
given	give	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.38	0.38	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
came	come	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
0.25	0.25	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
was	be	VBD	B-VP	O
undetectable	undetectable	JJ	B-ADJP	O
.	.	.	O	O

With	With	IN	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
her	her	PRP$	B-NP	O
p.o.	p.o.	NN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
were	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
metoprolol	metoprolol	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
75	75	CD	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
low-grade	low-grade	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
one	one	CD	B-NP	O
UA	UA	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
bacteria	bacteria	NNS	B-NP	O
but	but	CC	O	O
which	which	WDT	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
given	give	VBN	I-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
process	process	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
and	and	CC	O	O
covered	cover	VBN	B-VP	O
briefly	briefly	RB	B-ADVP	O
with	with	IN	B-PP	O
ceftazidine	ceftazidine	NN	B-NP	O
before	before	IN	B-PP	O
continuing	continue	VBG	B-VP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
tuberculosis	tuberculosis	NN	B-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
persistent	persistent	JJ	I-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PPD	PPD	NN	I-NP	B-protein
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
read	read	VBN	I-VP	O
at	at	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
6/15/06	6/15/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
allopurinol	allopurinol	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
concern	concern	NN	I-NP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
aspart	aspart	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
modest	modest	JJ	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
100s	100	NNS	I-NP	B-DNA
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Rheumatic	Rheumatic	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
chart	chart	NN	I-NP	O
of	of	IN	B-PP	O
polymyalgia	polymyalgia	NN	B-NP	O
rheumatica	rheumatica	NN	I-NP	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
familiar	familiar	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
ESR	ESR	NN	I-NP	B-protein
of	of	IN	B-PP	O
102	102	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
CRP	CRP	NN	I-NP	B-protein
of	of	IN	B-PP	O
184	184	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hilar	hilar	JJ	B-NP	O
adenopathy	adenopathy	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
previous	previous	JJ	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
scans	scan	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
ordered	order	VBN	I-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
evaluated	evaluate	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
SPEP	SPEP	NN	I-NP	B-protein
and	and	CC	I-NP	O
IPEP	IPEP	NN	I-NP	B-protein
were	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
gammopathy	gammopathy	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ANA	ANA	NN	B-NP	O
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
complement	complement	NN	B-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
antimitochondrial	antimitochondrial	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
tests	test	NNS	I-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
BMC	BMC	NNP	I-NP	B-cell_type
Rheumatology	Rheumatology	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Consultants	Consultant	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Chauncey	Chauncey	NNP	I-NP	O
Quandt	Quandt	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SMH	SMH	NNP	I-NP	O
Hematology	Hematology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
97.3	97.3	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
69	69	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
155/77	155/77	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
changed	change	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
clonidine	clonidine	NN	B-NP	O
0.1	0.1	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
losartan	losartan	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Reglan	Reglan	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ursodiol	ursodiol	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-7519810	3-7519810	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Eldridge	Eldridge	NNP	B-NP	O
Vince	Vince	NNP	I-NP	O
Virgili	Virgili	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Ford	Ford	NNP	I-NP	O
Ertbeach	Ertbeach	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LENBERG	LENBERG	NNP	B-NP	O
,	,	,	O	O
SEBASTIAN	SEBASTIAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LONCAR	LONCAR	NNP	B-NP	O
,	,	,	O	O
OMAR	OMAR	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8673981	8673981	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/11/06	10/11/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/29/06	9/29/06	CD	B-NP	O

